Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 1996

Primary Completion Date

January 31, 2007

Conditions

Sarcoma

Interventions

DRUG

daunorubicin hydrochloride

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (1)

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

lead

Roswell Park Cancer Institute

OTHER

NCT00002985 - Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter